Phase 1 27 trials
Phase 1
NCT07691450 Jan 2027 → Nov 2029 expected Nodal T-follicular helper cell lymphoma, follicular type , anaplastic large cell lymphoma , angioimmunoblastic T-cell lymphoma , enteropathy-associated T-cell lymphoma +6 City of Hope Medical Center
Not yet recruiting
No outcome recorded
Phase 1
NCT05627245 Mar 2023 → Jun 2027 expected diffuse large B-cell lymphoma germinal center B-cell type , follicular lymphoma , primary cutaneous T-cell lymphoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT05154994 Jan 2022 → Aug 2026 overdue infiltrating bladder urothelial carcinoma sarcomatoid variant University of Utah
Active not recruiting
No outcome recorded
Phase 1
NCT04315233 May 2021 → Mar 2024 breast cancer , ovarian carcinoma University of Utah
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT04703920 Mar 2021 → Dec 2024 breast cancer , castration-resistant prostate carcinoma , ovarian carcinoma , pancreatic adenocarcinoma University of Michigan Rogel Cancer Center
Completed
No outcome recorded
Phase 1
NCT04315155 Oct 2020 → Sep 2023 adenocarcinoma University of Utah
Withdrawn
No outcome recorded
Stop: Business
Phase 1
NCT04184869 Aug 2019 → Dec 2022 cancer , hematopoietic and lymphoid cell neoplasm Acrotech Biopharma Inc.
Completed
No outcome recorded
Phase 1
NCT03772925 Jun 2019 → Sep 2022 acute myeloid leukemia , myelodysplastic syndrome National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT03432741 Mar 2018 → Aug 2022 Hodgkins lymphoma , breast adenocarcinoma , mycosis fungoides , nodal marginal zone B-cell lymphoma Mayo Clinic
Terminated
No outcome recorded
Stop: Business
Phase 1
NCT02875002 Oct 2016 → Mar 2018 lymphoma Yale University
Withdrawn
No outcome recorded
Phase 1
NCT02680795 Apr 2016 → Jul 2020 cancer , hematopoietic and lymphoid cell neoplasm Acrotech Biopharma Inc.
Completed
No outcome recorded
Phase 1
NCT02679131 Mar 2016 → Jun 2017 refractory malignant neoplasm Acrotech Biopharma Inc.
Terminated
No outcome recorded
Phase 1
NCT02532192 Dec 2015 → Dec 2019 lymphoma M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1
NCT02381548 Aug 2015 → May 2018 blast phase chronic myelogenous leukemia, BCR-ABL1 positive , myelodysplastic syndrome , therapy related acute myeloid leukemia and myelodysplastic syndrome National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT02142530 Oct 2014 → Mar 2017 diffuse large B-cell lymphoma , follicular lymphoma , mantle cell lymphoma , peripheral T-cell lymphoma, not otherwise specified Massachusetts General Hospital
Completed
No outcome recorded
Phase 1
NCT01583777 Sep 2013 → Apr 2015 —
Acrotech Biopharma Inc.
Completed
No outcome recorded
Phase 1
NCT01839097 May 2013 → Jan 2016 peripheral T-cell lymphoma, not otherwise specified Acrotech Biopharma Inc.
Completed
No outcome recorded
Phase 1
NCT01273155 Jan 2011 → Oct 2017 lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01317927 Dec 2010 → Jun 2015 cancer , hematopoietic and lymphoid cell neoplasm Spectrum Pharmaceuticals, Inc
Completed
No outcome recorded
Phase 1
NCT01075425 May 2010 → Feb 2015 acute lymphoblastic leukemia , acute myeloid leukemia , chronic myeloid leukemia , myelodysplastic syndrome Virginia Commonwealth University
Completed
No outcome recorded
Phase 1
NCT00926640 Jul 2009 → Jun 2017 small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00334789 Jun 2006 → Mar 2018 neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00351975 Jun 2006 → Mar 2013 acute myeloid leukemia with t(8;21)(q22;q22) translocation , acute myeloid leukemia with t(9;11)(p22;q23) , acute myeloid leukemia, inv(16)(p13.1;q22) , acute myeloid leukemia, t(16;16)(p13.1;q22) +8 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00413075 Jun 2006 → Aug 2011 cancer , lymphoma Valerio Therapeutics
Completed
No outcome recorded
Phase 1
NCT00354185 May 2006 → Feb 2008 Burkitt lymphoma , Hodgkins lymphoma , MALT lymphoma , Waldenstrom macroglobulinemia +15 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00348985 Mar 2006 → Jan 2010 Burkitt lymphoma , Hodgkins lymphoma , MALT lymphoma , Waldenstrom macroglobulinemia +13 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00413322 Sep 2005 → Mar 2008 neoplasm Valerio Therapeutics
Completed
No outcome recorded
Show 17 more trials Phase 1/2 9 trials
Phase 1/2
NCT02701673 Jun 2016 → Jun 2019 lymphoma M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1/2
NCT01310244 Dec 2010 → Aug 2015 non-small cell lung carcinoma Acrotech Biopharma Inc.
Completed
No outcome recorded
Phase 1/2
NCT01188707 Oct 2010 → Jun 2011 non-small cell lung carcinoma Herlev Hospital
Terminated
No outcome recorded
Phase 1/2
NCT01090830 Apr 2010 → Feb 2012 non-small cell lung carcinoma Holy Cross Hospital, Florida
Terminated
No outcome recorded
Phase 1/2
NCT01100944 Mar 2010 → Oct 2015 thymic carcinoma , thymoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1/2
NCT00878722 Aug 2007 → May 2009 acute myeloid leukemia Valerio Therapeutics
Completed
No outcome recorded
Phase 1/2
NCT00878800 Dec 2006 → Oct 2012 soft tissue sarcoma Valerio Therapeutics
Completed
No outcome recorded
Phase 1/2
NCT00321594 May 2006 → Aug 2010 adult hepatocellular carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00421889 Aug 2005 → Feb 2009 fallopian tube cancer , malignant epithelial tumor of ovary , urinary bladder cancer Valerio Therapeutics
Completed
No outcome recorded
Phase 2 18 trials · 2 missed
Phase 2
NCT06406465 Oct 2026 → Jul 2027 expected small cell carcinoma National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT05170334 Dec 2021 → Dec 2025 overdue uveal melanoma H. Lee Moffitt Cancer Center and Research Institute
Active not recruiting
No outcome recorded
Phase 2
NCT04340843 Sep 2020 → Feb 2024 overdue localized chondrosarcoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02737046 Dec 2016 → Dec 2024 adult T-cell leukemia/lymphoma University of Miami
Completed
No outcome recorded
Phase 2
NCT02137759 May 2014 → Aug 2023 brain glioblastoma Emory University
Unknown
No outcome recorded
Phase 2
NCT01686165 Aug 2012 → Feb 2016 anaplastic large cell lymphoma , diffuse large B-cell lymphoma , mantle cell lymphoma University of Arizona
Completed
Missed primary
Phase 2
NCT00993616 Dec 2009 → Jul 2012 Brenner tumor , fallopian tube cancer , ovarian clear cell cystadenocarcinoma , ovarian endometrioid adenocarcinoma +4 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00873119 Feb 2009 → Dec 2012 cancer of unknown primary site Valerio Therapeutics
Completed
No outcome recorded
Phase 2
NCT00865969 Dec 2008 → Nov 2013 peripheral T-cell lymphoma, not otherwise specified Spectrum Pharmaceuticals, Inc
Completed
No outcome recorded
Phase 2
NCT00589290 Dec 2007 → Jul 2013 thymic carcinoma , thymoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00431340 Mar → Jun 2007 plasma cell myeloma Valerio Therapeutics
Terminated
No outcome recorded
Phase 2
NCT00301756 Sep 2006 → Aug 2009 borderline epithelial tumor of ovary , fallopian tube carcinoma , ovarian carcinoma , primary peritoneal carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00365053 Jun 2006 → Mar 2009 sarcomatoid mesothelioma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00357162 May 2006 → Dec 2010 myelodysplastic syndrome National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00357032 May 2006 → Jul 2009 acute myeloid leukemia with 11q23 abnormalities , acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) , acute myeloid leukemia with t(8;21)(q22;q22) translocation National Cancer Institute (NCI)
Completed
Missed primary
Phase 2
NCT00303953 Jan 2006 → Jan 2010 Burkitt lymphoma , diffuse large B-cell lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00274651 Jan 2006 → Jul 2009 peripheral T-cell lymphoma, not otherwise specified , primary cutaneous T-cell lymphoma Valerio Therapeutics
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT00131261 Jan 2005 → Jan 2007 plasma cell myeloma Valerio Therapeutics
Completed
No outcome recorded
Show 8 more trials Comparator or background therapy 3 trials
Phase 2
NCT04747236 Comparator Feb 2021 → Jun 2028 expected —
University of Virginia
Recruiting
No outcome recorded
Phase 3
NCT06561048 Comparator Oct 2024 → Nov 2027 expected Nodal T-follicular helper cell lymphoma, follicular type , anaplastic large cell lymphoma , angioimmunoblastic T-cell lymphoma , peripheral T-cell lymphoma, not otherwise specified Corvus Pharmaceuticals, Inc.
Recruiting
No outcome recorded
Phase 3
NCT06072131 Comparator Oct 2023 → Jul 2030 expected peripheral T-cell lymphoma, not otherwise specified Acrotech Biopharma Inc.
Recruiting
No outcome recorded